Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-014681

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jennifer Balliet
Officer — VP and Chief Culture Officer
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F7$8.03Feb 26, 2018A72,500AFeb 26, 2019Feb 26, 2023Common Stock72,50072,500D
Stock Option (Right to Buy)F1$4.78holding———May 4, 2016May 4, 2020Common Stock120,000120,000D
Stock Option (Right to Buy)F2$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock50,00050,000D
Stock Option (Right to Buy)F3$7.52holding———Apr 28, 2018Apr 28, 2022Common Stock60,00060,000D
Restricted StockF4,F5,F6$0.00holding———May 25, 2018—Common Stock20,00020,000D

Explanation of responses